BIONTECH SE

BNTX
Real-time Estimate Quote. Real-time Estimate  - 03/02 11:54:10 am
107.265USD -2.67%

Turn to zoom
Prev.110.2100
Open109.8600
High109.8600
Low106.2300
Volume316 120
Latest news
8m ago
25m ago
1h ago
2h ago
Chart BIONTECH SE
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishNeutralBullish
Resistance120130127
Spread/Res.-11%-18%-16%
Spread/Supp.-2,4%84%46%
Support10957,873,0
Financials
Sales 2020 432 M 519 M 519 M
Net income 2020 -381 M -458 M -458 M
Net cash 2020 836 M 1 005 M 1 005 M
P/E ratio 2020 -57,6x
Yield 2020 -
Capitalization 22 026 M 26 537 M 26 489 M
EV / Sales 2020 49,1x
EV / Sales 2021 2,88x
Nbr of Employees 1 800
Free-Float 90,2%
Company
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. It develops a broad product pipeline using different scientific approaches and technology platforms, including...

>> Read more
Sector :
Bio Therapeutic Drugs
Calendar :
2021-03-02 Presentation
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus OUTPERFORM
Number of Analysts 11
Average target price 94,33 €
Last Close Price 91,48 €
Spread / Highest target 22,7%
Spread / Average Target 3,12%
Spread / Lowest Target -31,6%